Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.
Quick Stats
Jan 30, 202651.4
AI Score
HOLD0.76
Volume Ratio
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
RNTX Stock Summary
Last updated Jan 30, 2026
RNTX is currently trading at $1.3, positioned below its 200-day moving average of $1.45, suggesting bearish momentum. The stock has a 52-week range of $1.02 to $2.96.
Technical Analysis: The 50-day moving average stands at $1.34, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.68, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.135, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RNTX at 51.4/100 with a HOLD recommendation.
RNTX (Rein Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.68 |
| CMF (20) | 0.135 |
| ROC (10) | 12.069 |
| ADX (14) | 19.834 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.034 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -60.0 |
| MFI (14) | 50.692 |
RNTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RNTX Price vs Max Options Open Interest
RNTX Max Change In Options Open Interest
RNTX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RNTX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RNTX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RNTX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Rein Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RNTX Moving Averages Analysis
Rein Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
RNTX (Rein Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.38 |
| 20 | 1.28 |
| 30 | 1.28 |
| 50 | 1.34 |
| 100 | 1.32 |
| 200 | 1.45 |
RNTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 37.6 million |
| Earnings/Share ($) | -2.94 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.955 |
| EPS Estimate Next Year ($) | -0.8 |
| WallStreet Target Price ($) | 10 |
| Most Recent Quarter |